Table of Contents Table of Contents
Previous Page  39 / 1601 Next Page
Information
Show Menu
Previous Page 39 / 1601 Next Page
Page Background

The proof is in the pudding:

Margins too large ??

• No (few) marginal

recurrence

• Might limit dose

escalation and lead

to in-field

recurrence

Due et al R&O 2014